Dialog Box

Children's Tumour Foundation of Australia

2022 Australian NF Clinical Symposium

An opportunity for health professionals and researchers to come together (hybrid and virtual) to network and discuss the latest in medical management, treatment and research into neurofibromatosis in Australia and around the globe.

8:45AM - 6:30PM Friday 19th August 2022
Melbourne, VIC
In Person - 2022 NF Symposium
$150

Includes event entry, catering and networking session

Virtual - 2022 NF Symposium
$100

Includes all information required to attend event virtually

An event exclusively for doctors, clinical specialists, scientists and allied health practitioners who have an interest, or are working in the field of neurofibromatosis (NF).

Following on from the success of the 2020 sell-out event, the Children’s Tumour Foundation welcomes you to once again enjoy a full day event showcasing both Australian and international speakers sharing their knowledge of NF.

Register to attend the 2022 Australian NF Clinical Symposium in Melbourne, Australia this August.

Together we will explore ground-breaking medical advancements made over the past two years, and gain exclusive insight into the current projects from around the world, paving the way for a brighter future for all people living with NF. 

The occasion will be one of the first opportunities since the beginning of the COVID pandemic for NF researchers, scientists, clinicians and specialists  from Australia to come together in person once again.

To allow people to attend from anywhere in Australia or around the world, we will also be streaming the event live for registered participants.  However, those attending in person, are also invited to attend an important networking event after the Symposium.

Download the symposium FLYER here.

The day’s full agenda and further notable speaker profiles will be made available in due course. 

PRESENTATIONS

INTERNATIONAL PRESENATION - MANAGEMENT OF NF2
Prof D Gareth Evans MB BS MD FRCP FLSW FRCOG ad eundem

Professor of Medical Genetics and Cancer Epidemiology, The University of Manchester

AUTISM & NF1 NEW EVIDENCE
Associate Professor Jonathan Payne DPsych
Co-Group Leader/Principal Research Fellow, Brain and Mind, Murdoch Children's Research Institute
Senior Clinical Neuropsychologist, Mental Health, The Royal Children's Hospital
Honorary Principal Fellow, Department of Paediatrics, The University of Melbourne

THE STRUCTURE OF HUMAN NEUROFIBROMIN (NF1)
Dr Andrew Ellisdon, BBiomedSci (Hons) PhD
Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia
Victorian Cancer Agency Mid-Career Fellow

NF DIAGNOSTIC CRITERIA UPDATE
Associate Professor Yemima Berman, BMBS FRACP BSc (Hons) PhD Medicine
Head, Department of Clinical Genetics, Royal North Shore Hospital
Vice President, Human Genetics Society of Australasia
MD Research Coordinator, University of Sydney Northern Clinical School

LATEST ON THE TiNT TRIAL
Dr Geoff McCowage MBBS (Hons) FRACP
Senior Paediatric Oncologist Children's Hospital Westmead
CEO of Australasian Children’s Cancer Trials
Lead clinician for the first Australian-led clinical trial of the MEK Inhibitor drug, Trametinib.

HEARING PRESERVATION IN NF2
Mr Nicholas Hall, MBBS BMedSci (Hons) FRACS
Neurosurgeon Royal Melbourne Hospital, Melbourne Private Hospital, Geelong neurosurgery at Epworth hospital

CHARACTERISING SLEEP DISTURBANCE IN CHILDREN WITH NF1
Preliminary Findings from the NF1 Sleep Study

Dr Natalie Pride Masters of Neuropsychology, PhD
Clinical Neuropsychologist, Children's Hospital Westmead

TRANSITIONING TO ADULTHOOD
Professor Kate Drummond AM MBBS MD FRACS

Director of Neurosurgery, Royal Melbourne Hospital
Head of Central Nervous System Tumours, VCCC Chair, PANGEA Global Health Education

MAGEN Update
Dr Gabriel Dabscheck MBBS Hons FRACP MClinEpi
Malignant Peripheral Nerve Sheath Tumour Genomics in Neurofibromatosis Type 1
The Royal Children’s Hospital Paediatric Neurologist

As we anticipate this will be a popular event, seats are limited and will only be secured with completed registration and payment.


FULL EVENT DETAILS

Date: Friday 19 August 2022

Location:  Peter MacCallum Cancer Centre, 305 Grattan Street MELBOURNE VIC 3000

Start Time: Registrations open 8:45 am with the first session to commence at 9:15 am

Finish time: 5:30pm (NF Networking Event 5.30pm - 6:30pm)

In-Person Registration: $150.00 (Includes event entry, catering and networking session)

Virtual Registration: $100 (includes access to live-streamed event)

Interstate delegates are now invited to submit application for up to a $500 travel bursary to contribute to the costs of travel and accommodation required for attendance at this year’s symposium in Melbourne. This opportunity is intended to support delegates who do not have access to conference and travel funding to attend.**


25% OFF PROMO CODE FOR STUDENTS: SYMPOSIUM25%



If you would like to submit an abstract or case study, you can do so by CLICKING THIS LINK


SPONSORED BY


Donate